Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021
Characteristic
Percentage of Canadians
Agree
41%
Somewhat agree
28%
Somehwat disagree
2%
Disagree
3%
Unsure
26%
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Original question: "Do you approve, somewhat approve, somewhat disapprove or disapprove Q of the following uses for mushroom-based psilocybin-assisted therapy: Allowing the controlled medical use of mushroom-based psilocybin-assisted psychotherapy for Post-Traumatic Stress Disorders (PTSD)."
Citation formats
Share of Canadians who approve of psilocybin-assisted psychotherapy for PTSD in 2021
As of 2021, around 41 percent of all Canadians aged 18 years and older stated that they approved of medical use of psilocybin-assisted psychotherapy for treating post-traumatic stress disorders. This statistic illustrates the percentage of Canadian adults who approved of the medical use of psilocybin-assisted psychotherapy to treat post-traumatic stress disorders in 2021.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Canadian Psychedelic Association. (August 4, 2021). Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. "Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021." Chart. August 4, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. (2021). Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. "Percentage of Canadian Adults Who Approved of Allowing Psilocybin-assisted Psychotherapy to Be Used to Medically Treat Post-traumatic Stress Disorders in 2021." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 4 Aug 2021, /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association, Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 ÌÇÐÄÆƽâ°æ, /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/ (last visited August 04, 2026)
Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 [Graph], Canadian Psychedelic Association, August 4, 2021. [Online]. Available: /statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
